Entrada TherapeuticsTRDA
那斯達克 · USD
13.88
+0.73
(+5.55%)
收盤 04/07 03:58 (UTC+8)
04/07 03:58 (UTC+8)
Entrada TherapeuticsTRDA
13.88
+0.73
(+5.55%)
財務數據
損益表
- 0.44
- 0.42
- 0.59
- 0.95
- 0.20
- 0.37
- 0.21
- 0.02
- 0.02
- 0.01
- 140.70
- -4.31
- 41.27
- 60.17
- -79.33
- 91.10
- -45.03
- -90.51
- -17.23
- -19.52
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 1,299 | 1,614 | 1,950 | 20,558 | 37,398 | 19,570 | 94,694 | 59,120 | 41,848 | 43,735 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 1,299 | 1,614 | 1,950 | 20,558 | 37,398 | 19,570 | 94,694 | 59,120 | 41,848 | 43,735 |
營業費用 | 43,507 | 48,665 | 48,799 | 42,348 | 43,265 | 41,228 | 41,271 | - | 36,943 | 29,723 |
研發費用 | 33,957 | 38,361 | 37,877 | 32,074 | 33,406 | 31,257 | 32,035 | 28,608 | 28,291 | 22,191 |
推銷及管理費用 | 9,550 | 10,304 | 10,922 | 10,274 | 9,859 | 9,971 | 9,236 | 9,399 | 8,652 | 7,532 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -42,208 | -47,051 | -46,849 | -21,790 | -5,867 | -21,658 | 53,423 | 21,113 | 4,905 | 14,012 |
其他收入及費用 | 3,136 | 3,571 | 3,924 | 4,441 | 5,128 | 5,766 | 4,366 | 4,214 | 4,292 | 4,051 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -39,072 | -43,480 | -42,925 | -17,349 | -739 | -15,892 | 57,789 | 25,327 | 9,197 | 18,063 |
所得稅 | 92 | 654 | 178 | - | -1,870 | -1,860 | 2,758 | 1,831 | 18,741 | -17,398 |
稅後純益 | -39,164 | -44,134 | -43,103 | -17,349 | 1,131 | -14,032 | 55,031 | 23,496 | -9,544 | 35,461 |
基本每股稅後盈餘(元) | -0.94 | -1.06 | -1.04 | -0.42 | 0.03 | -0.35 | 1.61 | 0.70 | - | 1.07 |
稀釋每股稅後盈餘(元) | -0.94 | -1.06 | -1.05 | -0.42 | -0.04 | -0.51 | 1.55 | 0.68 | -0.28 | 1.07 |
基本平均股數(千股) | 41604.00 | 41462.00 | 41338.00 | 41073.00 | 40842.00 | 40629.00 | 34180.00 | 33497.00 | - | 33281.00 |
稀釋平均股數(千股) | 41604.00 | 41462.00 | 41338.00 | 41073.00 | 43050.00 | 40629.00 | 35507.00 | 34790.00 | - | 34775.00 |
還原基本每股稅後盈餘(元) | -0.94 | -1.06 | -1.04 | -0.42 | 0.03 | -0.35 | 1.61 | 0.70 | - | 1.07 |
還原稀釋每股稅後盈餘(元) | -0.94 | -1.06 | -1.05 | -0.42 | -0.04 | -0.51 | 1.55 | 0.68 | -0.28 | 1.07 |
還原基本平均股數(千股) | 41,604 | 41,462 | 41,338 | 41,073 | 40,842 | 40,629 | 34,180 | 33,497 | - | 33,281 |
還原稀釋平均股數(千股) | 41,604 | 41,462 | 41,338 | 41,073 | 43,050 | 40,629 | 35,507 | 34,790 | - | 34,775 |
EBITDA(千元) | -38,819 | -42,989 | -42,852 | -17,741 | -2,254 | -18,168 | 56,438 | 24,224 | 7,934 | 17,045 |